跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP
Authorized
STANDARD
LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bad9d8bb1304e1a3
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
bad9d8bb1304e1a3
Drug Approval Canada Name
LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP
Product Name
LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP
Status
Dormant
Status Date
2022-06-29
Original Market Date
2020-03-02
Din
02458128
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:08.00
Atc Original
D04AB01 LIDOCAINE
Atc Name
d 04 ab 01
Aig Number
0101280002
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
LIDOCAINE HYDROCHLORIDE
4 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bad9d8bb1304e1a3
Type
Standard
Back to Health Canada Approvals